Inmune Bio Inc. (INMB)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
1. 90
-0.17
-8.2126%
$
53.7M Market Cap
- P/E Ratio
- Div Yield
796,500 Volume
-2.19 Eps
$ 2.07
Previous Close 
Want to track INMB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Inmune Bio Inc. (INMB) Statistics
Valuation metrics
Market Cap 53.7M
Enterprise value 30.66M
Trailing P/E (ttm) -1.12
Forward P/E -
PEG ratio -1.27
Price/Sales (ttm) -
Price/Book (mrq) 2.57
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.22
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 788.89K
Average volume (90 days) 405.48K
Price summary
52-Week low 1.09
52-Week high 3.24
Beta -
50-Day moving average 1.41
200-Day moving average 1.42
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.61%
Return on equity -1.71%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.56
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.8
Total debt (mrq) -
Total Debt/Equity (mrq) 0.08
Current ratio (mrq) 4.24%
Book value per share (mrq) 0.74
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
